Filter Results
:
(978)
Show Results For
-
All HBS Web
(3,565)
- Faculty Publications (978)
Show Results For
-
All HBS Web
(3,565)
- Faculty Publications (978)
Page 1 of
978
Results
→
- March–April 2024
- Article
How Fast Should Your Company Really Grow?
By: Gary P. Pisano
Growth—in revenues and profits—is the yardstick by which the competitive fitness and health of organizations is measured. Consistent profitable growth is thus a near universal goal for leaders—and an elusive one.
To achieve that goal, companies need a growth... View Details
To achieve that goal, companies need a growth... View Details
Keywords:
Growth and Development Strategy;
Growth Management;
Business Growth and Maturation;
Business Strategy;
Organizational Culture
Pisano, Gary P. "How Fast Should Your Company Really Grow?" Harvard Business Review 102, no. 2 (March–April 2024): 38–45.
- March 2024
- Case
AMC: The Zero Revenue Case
By: C. Fritz Foley and Donal O'Cofaigh
The onset of the Covid-19 pandemic put theatre company AMC’s already perilous financial situation under even further strain. The company’s high levels of debt resulted in a monthly cash-burn which left it facing an imminent Chapter-11 filing in the absence of...
View Details
- March 2024 (Revised March 2024)
- Case
Supercell: Clash of Plans, Restructuring the Mobile Game Development Company
By: Jeffrey F. Rayport and George Gonzalez
Founded in 2010, Supercell was a Helsinki, Finland-based mobile gaming company that had developed and launched five global hit mobile games: Clash of Clans, Clash Royale, Hay Day, Brawl Stars, and Boom Beach. The company’s early philosophy was that it could produce...
View Details
- March 2024
- Case
Amperity: First-Party Data at a Crossroads
By: Elie Ofek, Hema Yoganarasimhan and Alexis Lefort
In the summer of 2023, Amperity management was facing a critical decision on its future direction. Given the dramatic changes occurring within the digital advertising ecosystem, as concerns over consumer privacy placed limits on the ability to engage in third-party...
View Details
- March 2024
- Article
Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act
By: Matthew Vogel, Pragya Kakani, Amitabh Chandra and Rena M. Conti
The Inflation Reduction Act (IRA) requires Medicare to negotiate lower prices for some medicines with high Medicare spending. Using historical data from public and proprietary sources to apply the IRA's negotiation criteria retrospectively, we identify all drugs that...
View Details
Keywords:
Policy;
Government Legislation;
Health Care and Treatment;
Negotiation;
Price;
Pharmaceutical Industry
Vogel, Matthew, Pragya Kakani, Amitabh Chandra, and Rena M. Conti. "Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act." Nature Biotechnology 42, no. 3 (March 2024): 406–412.
- March 2024
- Module Note
Navigating the Future: Managing Financial Forecasts
By: Mark Egan
This module note guides instructors on delivering a course module that focuses on understanding, developing, and using financial forecasts from a chief financial officer’s (CFO) perspective. The cases in the module equip students with an understanding of the techniques...
View Details
Egan, Mark. "Navigating the Future: Managing Financial Forecasts." Harvard Business School Module Note 224-075, March 2024.
- March 2024
- Article
The Asymmetric Mispricing Information in Analysts’ Target Prices
By: Jeremiah Green, John R. M. Hand and Anywhere Sikochi
We study the mispricing information present in the target prices of U.S. and international analysts. We hypothesize that asymmetry in the value-relevance of the information that managers supply to analysts, combined with asymmetry in the incentives facing analysts to...
View Details
Keywords:
Analysts;
Target Prices;
Mispricing;
Cost Of Equity;
Valuation;
Price;
Cost;
Analysis;
Theory
Green, Jeremiah, John R. M. Hand, and Anywhere Sikochi. "The Asymmetric Mispricing Information in Analysts’ Target Prices." Review of Accounting Studies 29, no. 1 (March 2024): 889–915.
- February 2024
- Teaching Note
AB InBev: Brewing Up Forecasts during COVID-19
By: Mark Egan and C. Fritz Foley
Teaching Note for HBS Case No. 224-020. In July 2021, the CEO of AB InBev's European operations and his team strategized to position the company for success post-pandemic. As the world's largest beer company, boasting over 500 brands, revenue of $46 billion, and a...
View Details
- February 2024
- Case
Innovation Strategy at Stanley Black & Decker: Setting the Direction for Growth
By: David L. Ager and Antonio Manuel Oftelie
On July 1, 2022, Don Allan was appointed Chief Executive Officer of Stanley Black & Decker (SBD). Although Allan had been with the firm for 23 years, most recently serving as President and Chief Financial Officer, he recognized that he was stepping into his new role as...
View Details
- February 2024
- Case
Continuity & Change at Boston Consulting Group
By: David G. Fubini, Suraj Srinivasan and David Lane
As the new CEO of Boston Consulting Group (BCG) since autumn 2021, Christoph Schweizer had big shoes to fill—his predecessor, Rich Lesser, had tripled the partnership’s total revenues and created digital initiatives that contributed 40+% of 2021 revenues, more than...
View Details
Keywords:
Business Growth and Maturation;
Business Organization;
Change Management;
Talent and Talent Management;
Governance;
AI and Machine Learning;
Environmental Sustainability;
Leading Change;
Risk Management;
Organizational Culture;
Organizational Design;
Partners and Partnerships;
Consulting Industry
Fubini, David G., Suraj Srinivasan, and David Lane. "Continuity & Change at Boston Consulting Group." Harvard Business School Case 124-011, February 2024.
- February 2024
- Case
ReSpo.Vision: The Kickstart of an AI Sports Revolution
By: Paul A. Gompers, Elena Corsi and Nikolina Jonsson
This case study explores the growth journey of Polish computer vision sports start-up ReSpo.Vision in an emerging entrepreneurial ecosystem. By providing 3D data and analysis to soccer clubs, ReSpo.Vision achieved significant milestones with a €1 million seed round, an...
View Details
Keywords:
Business Startups;
Business Plan;
Experience and Expertise;
Talent and Talent Management;
Decisions;
Decision Choices and Conditions;
Forecasting and Prediction;
Entrepreneurship;
Venture Capital;
AI and Machine Learning;
Analytics and Data Science;
Applications and Software;
Sports Industry;
Technology Industry;
Poland;
Europe
- February 2024
- Case
Tabby: Winning Consumers' Digital Wallets
By: Eva Ascarza and Fares Khrais
Hosam Arab (MBA 2009), cofounder and CEO of Tabby, a Saudi-based fintech startup, raised its Series D funding round in October 2023, four years after its inception, valuing it as a regional unicorn. Tabby's core product, a buy-now-pay-later (BNPL) service, allowed...
View Details
Ascarza, Eva, and Fares Khrais. "Tabby: Winning Consumers' Digital Wallets." Harvard Business School Case 524-056, February 2024.
- February 2024
- Case
FIGS: Scrubbing the Status Quo
By: Jeffrey F. Rayport and Nicole Tempest Keller
In October 2023, FIGS had revolutionized the medical scrubs industry with its fashionable and functional designs, but the venture was at a critical juncture. The digitally native vertical brand (DNVB) had gone public in a successful IPO in 2021 and reached $500 million...
View Details
- January 2024
- Case
Frank Cornelissen: The Great Sulfite Debate (A)
By: Tiona Zuzul and Susan Pinckney
In 2018, artisanal Italian vineyard Frank Cornelissen was one of the world’s leading natural wine vineyards. Its founder, Frank Cornelissen, faced weather related conditions that forced him to have to decide between staying true to the tenets of the natural wine...
View Details
Keywords:
Budgets and Budgeting;
Business Earnings;
Plant-Based Agribusiness;
Family Business;
For-Profit Firms;
Small Business;
Change Management;
Transition;
Communication Strategy;
Cost vs Benefits;
Financial Management;
Financial Strategy;
Profit;
Revenue;
Spending;
Global Strategy;
Goods and Commodities;
Innovation Strategy;
Crisis Management;
Goals and Objectives;
Growth Management;
Success;
Strategic Planning;
Problems and Challenges;
Risk and Uncertainty;
Cognition and Thinking;
Reputation;
Adaptation;
Expansion;
Weather;
Mission and Purpose;
Values and Beliefs;
Food and Beverage Industry;
Food and Beverage Industry;
Europe;
Italy
Zuzul, Tiona, and Susan Pinckney. "Frank Cornelissen: The Great Sulfite Debate (A)." Harvard Business School Case 724-391, January 2024.
- January 2024
- Teaching Note
Frank Cornelissen: The Great Sulfite Debate (A) & (B)
By: Tiona Zuzul
Teaching Note for HBS Case Nos. 724-391 and 724-398. In 2018, artisanal Italian vineyard Frank Cornelissen was one of the world’s leading natural wine vineyards. Its founder, Frank Cornelissen, faced weather related conditions that forced him to have to decide between...
View Details
Keywords:
Budgets and Budgeting;
Business Earnings;
Agribusiness;
Plant-Based Agribusiness;
Family Business;
For-Profit Firms;
Small Business;
Change Management;
Transition;
Communication Strategy;
Decision Making;
Cost vs Benefits;
Financial Management;
Financial Strategy;
Profit;
Revenue;
Spending;
Globalization;
Global Strategy;
Goods and Commodities;
Innovation Strategy;
Crisis Management;
Goals and Objectives;
Growth Management;
Success;
Strategic Planning;
Problems and Challenges;
Risk and Uncertainty;
Cognition and Thinking;
Reputation;
Strategy;
Adaptation;
Expansion;
Mission and Purpose;
Values and Beliefs;
Food and Beverage Industry;
Europe;
Italy
- January 2024
- Supplement
Frank Cornelissen: The Great Sulfite Debate (B)
By: Tiona Zuzul and Susan Pinckney
In 2018, artisanal Italian vineyard Frank Cornelissen was one of the world’s leading natural wine vineyards. Its founder, Frank Cornelissen, faced weather related conditions that forced him to have to decide between staying true to the tenets of the natural wine...
View Details
Keywords:
Budgets and Budgeting;
Business Earnings;
Plant-Based Agribusiness;
Business Startups;
Family Business;
For-Profit Firms;
Small Business;
Change Management;
Transition;
Communication;
Cost vs Benefits;
Decisions;
Entrepreneurship;
Environmental Sustainability;
Values and Beliefs;
Financial Management;
Financial Strategy;
Profit;
Revenue;
Spending;
Global Strategy;
Goods and Commodities;
Innovation Strategy;
Crisis Management;
Goals and Objectives;
Growth Management;
Success;
Strategic Planning;
Problems and Challenges;
Risk and Uncertainty;
Cognition and Thinking;
Reputation;
Adoption;
Expansion;
Weather;
Mission and Purpose;
Food and Beverage Industry;
Food and Beverage Industry;
Europe;
Italy
Zuzul, Tiona, and Susan Pinckney. "Frank Cornelissen: The Great Sulfite Debate (B)." Harvard Business School Supplement 724-398, January 2024.
- January 2024
- Case
Pioneer Natural Resources: Enhancing the Capital Return Strategy with Variable Dividends
In February 2021, Scott Sheffield, the CEO of Pioneer Natural Resources (an independent oil and gas company based in Texas), was considering the possibility of enhancing the firm’s capital return strategy by introducing a variable dividend tied to cash flows in...
View Details
- January 2024
- Supplement
Accounting Red Flags or Red Herrings at Catalent? (B)
By: Joseph Pacelli, ZeSean Ali and Tom Quinn
GlassHouse Research identified accounting red flags at Catalent. Fiat Lux Partners countered most of GlassHouse’s claims. Who was right? This update explores the aftermath of the short seller duel.
View Details
Keywords:
Accounting Audits;
Acquisition;
Budgets and Budgeting;
Business Earnings;
Earnings Management;
Cost Accounting;
Fair Value Accounting;
Financial Reporting;
Revenue Recognition;
Integrated Corporate Reporting;
Fairness;
Moral Sensibility;
Values and Beliefs;
Government Legislation;
Conflict of Interests;
Announcements;
Blogs;
Debates;
Lawsuits and Litigation;
Stocks;
Performance Productivity;
Pharmaceutical Industry;
Accounting Industry;
United States
- January 2024
- Article
Cost of Exempting Sole Orphan Drugs from Medicare Negotiation
By: Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim and Benjamin N. Rome
Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease.
Objective: To estimate Medicare spending and global... View Details
Objective: To estimate Medicare spending and global... View Details
Vogel, Matthew, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim, and Benjamin N. Rome. "Cost of Exempting Sole Orphan Drugs from Medicare Negotiation." JAMA Internal Medicine 184, no. 1 (January 2024): 63–69.
- December 2023
- Article
Advances in Power-to-Gas Technologies: Cost and Conversion Efficiency
By: Gunther Glenk, Philip Holler and Stefan Reichelstein
Widespread adoption of hydrogen as an energy carrier is widely believed to require continued advances in Power-to-Gas (PtG) technologies. Here we provide a comprehensive assessment of the dynamics of system prices and conversion efficiency for three currently prevalent...
View Details
Keywords:
Clean Technology;
Green Hydrogen;
Carbon Emissions;
Decarbonization;
Learning By Doing;
Environment;
Energy;
Environmental Accounting;
Environmental Management;
Sustainable Cities;
Cost Accounting;
Innovation and Management;
Technology Adoption;
Energy Policy;
Engineering;
Green Technology;
Energy Industry;
Utilities Industry;
Industrial Products Industry;
Manufacturing Industry;
Transportation Industry;
North America;
South America;
Africa;
Europe;
Asia
Glenk, Gunther, Philip Holler, and Stefan Reichelstein. "Advances in Power-to-Gas Technologies: Cost and Conversion Efficiency." Energy & Environmental Science 16, no. 12 (December 2023): 6058–6070.